BioSig Technologies Advances AI Medical Device Platform with Collaborations and Funding

BioSig Technologies, Inc. is a prominent medical technology company that specializes in delivering unrivaled precision and accuracy in intracardiac signal visualization. In recent developments, the company has made significant progress in the research and development of an artificial intelligence (AI) medical device platform. This article provides an update on BioSig’s endeavors and collaborations in this field.

Inclusion in Nvidia’s Inception Partnership Program

In an exciting announcement on July 20, 2023, BioSig AI Sciences, Inc. (BAIS), a majority-owned subsidiary of BioSig, was selected to participate in Nvidia’s prestigious Inception partnership program. This partnership opens up new avenues for engineering and technology support, providing BioSig’s team with access to invaluable resources.

Seed round funding for BAIS

On July 23, 2023, BAIS successfully closed its seed round of funding, securing an impressive $2.2 million. This funding round enabled BAIS to solidify its position in the medical technology market, with the majority-owned subsidiary now valued at an impressive $15 million. This robust foundation enables the subsidiary to forge ahead with innovative research and development efforts.

Engaging with hospital customers

Within a month of closing the initial funding round, BAIS has been actively engaging with numerous hospital customers at the highest levels of leadership. These interactions have been fruitful, as BAIS has identified multiple opportunities to introduce its proprietary AI platform into the market. The enthusiasm displayed by these institutions underscores the potential value that BAIS’s technology can bring to the medical sector.

Collaboration Agreement with a Global Technology Organization

BioSig recently signed a significant collaboration agreement with a leading global technology organization. This partnership focuses on building essential data infrastructure that will facilitate the scaling of BioSig’s AI platform in high-volume and data-intensive hospital centers. By joining forces with this partner, BioSig aims to optimize the platform’s capabilities and ensure its seamless integration into healthcare ecosystems worldwide.

CEO Statement on Growth Opportunities

Kenneth Londoner, Chairman & CEO of BioSig, has expressed his excitement and confidence in the future of the company. With over 30 years of experience in the technology marketplace, Londoner acknowledges the unparalleled growth opportunities that lie ahead. This optimism stems from the relationships cultivated by BioSig and the increasing commercial placements of their PURE EP™ platform technology. Combined with external technology collaborations and internal capabilities, BioSig expects to demonstrate substantial progress not only in 2023 but also in the years to come.

Market outlook for AI in healthcare

According to a report by Data Bridge Market Research, the AI in healthcare market is projected to experience exponential growth in the coming years. In 2022, the market was valued at $9.6 billion, and by 2030, it is estimated to reach a staggering $272.9 billion, with a compound annual growth rate (CAGR) of 51.9%. This data underscores the immense potential for AI technology in revolutionizing healthcare delivery and improving patient outcomes.

Importance of entrepreneurial and agile market participants

Leading hospitals are actively seeking innovative and agile emerging market participants to test and adopt AI-based solutions. BioSig, with its expertise and dynamic approach, fits the mold of what these hospitals are looking for. The company’s commitment to developing cutting-edge technology aligns with the demands and aspirations of the healthcare industry, thus positioning BioSig favorably in this rapidly evolving landscape.

BioSig Technologies has made significant strides in advancing its AI medical device platform through strategic collaborations and securing substantial funding. The inclusion in Nvidia’s Inception partnership program, completion of a successful seed round, engagement with hospital customers, and collaboration with a global technology organization all contribute to BioSig’s trajectory towards becoming a key player in the medical technology sector. With the projected growth of AI in healthcare, BioSig is well-positioned to make a lasting impact in the industry, improving patient care and outcomes through innovative AI-driven solutions.

Explore more

Why is LinkedIn the Go-To for B2B Advertising Success?

In an era where digital advertising is fiercely competitive, LinkedIn emerges as a leading platform for B2B marketing success due to its expansive user base and unparalleled targeting capabilities. With over a billion users, LinkedIn provides marketers with a unique avenue to reach decision-makers and generate high-quality leads. The platform allows for strategic communication with key industry figures, a crucial

Endpoint Threat Protection Market Set for Strong Growth by 2034

As cyber threats proliferate at an unprecedented pace, the Endpoint Threat Protection market emerges as a pivotal component in the global cybersecurity fortress. By the close of 2034, experts forecast a monumental rise in the market’s valuation to approximately US$ 38 billion, up from an estimated US$ 17.42 billion. This analysis illuminates the underlying forces propelling this growth, evaluates economic

How Will ICP’s Solana Integration Transform DeFi and Web3?

The collaboration between the Internet Computer Protocol (ICP) and Solana is poised to redefine the landscape of decentralized finance (DeFi) and Web3. Announced by the DFINITY Foundation, this integration marks a pivotal step in advancing cross-chain interoperability. It follows the footsteps of previous successful integrations with Bitcoin and Ethereum, setting new standards in transactional speed, security, and user experience. Through

Embedded Finance Ecosystem – A Review

In the dynamic landscape of fintech, a remarkable shift is underway. Embedded finance is taking the stage as a transformative force, marking a significant departure from traditional financial paradigms. This evolution allows financial services such as payments, credit, and insurance to seamlessly integrate into non-financial platforms, unlocking new avenues for service delivery and consumer interaction. This review delves into the

Certificial Launches Innovative Vendor Management Program

In an era where real-time data is paramount, Certificial has unveiled its groundbreaking Vendor Management Partner Program. This initiative seeks to transform the cumbersome and often error-prone process of insurance data sharing and verification. As a leader in the Certificate of Insurance (COI) arena, Certificial’s Smart COI Network™ has become a pivotal tool for industries relying on timely insurance verification.